Form D · Pharmaceuticals

DepYmed Inc.

Farmingdale, NY · CIK 0001851177

Offering snapshot reported Apr 25, 2025 · SEC filing

Reported sold
$250K
Offering amount: $250K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 9, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 25, 2025Initial$250,000No comparison1SEC filing
Feb 11, 2025Initial$250,000No comparison1SEC filing
Aug 16, 2024Initial$600,000No comparison2SEC filing
Mar 12, 2024Initial$500,000No comparison2SEC filing
May 4, 2023Initial$2,000,000No comparison2SEC filing
Apr 7, 2021Initial$5,550,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-544536

Source: Form D, filed Apr 25, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Samuel G. Backenroth Director
Andreas G. Grill Director, Executive
Leo Guthart Director
Shankar Hariharan Director
Peter Van Ness Executive
Steve Winick Director
Peter Young Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3 Bioscience Park Drive
Farmingdale, NY, 11735
Phone: (516) 662-8749